繁體中文 简体中文 Sitemap Previous Page
Catalog
leaflet
Cardiovascular Agents
Respriatory System Drugs
Antibiotics
Antimicrobial Agents
Digestive System Drugs
Urogenital System Drugs
Central Nervous System
Neuromuscular Disorder Drugs
Anti-Diabetic Agents
Vitamin Preparations
Syrup
Injection
External Agents
Ophthalmic Agents
:: Generics > Antibiotics
Product Picture
Type : 健保碼:A035929209
Name : Lisacef Inj.
Cephradine Carbonate 1.0gm (potency)
Description :
PRODUCTS
PRODUCT NO./PACKAGES
INGREDIENT/REG. NO.
MAIN INDICATIONS
DOSAGE AND USES
Lisacef Cap. 250mg、500mg

[Similar Product] Velosef



710960
1000 C
Each Cap. Contains :
Cephradine
(as monohydrate)
...250mg (potency)

Reg.No.036693(BE)

Cephradine
(as monohydrate)
....500mg (potency)

Reg.No 037125(BE)
MAIN INDICATIONS:
Infections caused by Staphylococcus,
Streptococcus,Pneumoniacoccus,
meningococcus and the other sensitive bacteries.

DOSAGE AND USES:
Adults :
urinary tract, gestrointestinal tract infection, 500mg every 6hrs (qid),respiratory tract, 250mg every 6hrs(qid).
Children :
25-50mg/kg daily in divided doses four times a day.

 

|
No.22, Chieh-shou Road, Taoyuan, Taiwan   TEL: 886-3-361-2131   FAX: 886-3-367-0029   E-mail: service@sintong.com   Copyright© 2019 International Trade Division